Expression of laminin α2 chain during normal and pathological growth of myocardium in rat and human

Cardiovascular Research

Volumn 46, Issue 2, 2000, Pages 346-355

  Oliviéro, Patricia ^a   Chassagne, Catherine ^a   Salichon, Nathalie ^a   Corbier, Alain ^b   Hamon, Gilles ^b   Marotte, Françoise ^a   Charlemagne, Danièle ^a   Rappaport, Lydie ^a   Samuel, Jane Lise ^a  

^a INSERM   (France)

^b SANOFI   (France)

Author keywords

Extracellular matrix; Hypertrophy

Indexed keywords

FIBRONECTIN; FLUORESCEIN; LAMININ; ISOPROTEIN; LAMININ ALPHA2; MESSENGER RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FETUS; HEART DILATATION; HEART HYPERTROPHY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; PRIORITY JOURNAL; RIBONUCLEASE PROTECTION ASSAY; ANALYSIS OF VARIANCE; ANIMAL; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; FETUS HEART; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEART; HEART MUSCLE; METABOLISM; RAT; RENOVASCULAR HYPERTENSION; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; CARDIOMYOPATHY, DILATED; EXTRACELLULAR MATRIX; FEMALE; FETAL HEART; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HEART; HUMANS; HYPERTENSION, RENOVASCULAR; LAMININ; MALE; MYOCARDIUM; PROTEIN ISOFORMS; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 0033625193     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00034-1     Document Type: Article

References (46)

1. Hay E.D. Cell biology of extracellular matrix. 2nd ed :1991;Plenum Press, New York.
2. Engvall E. Laminin variants. Why, where and when? Kidney Int. 43:(1):1993;2-6.
3. Henry M.D., Campbell K.P. Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton. Curr Opin Cell Biol. 8:(5):1996;625-631.
4. Ehrig K., Leivo I., Argraves W.S., Ruoslahti E., Engvall E. Merosin, a tissue-specific basement membrane protein, is a laminin-like protein. Proc Natl Acad Sci USA. 87:(9):1990;3264-3268.
5. Leivo I., Engvall E. Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proc Natl Acad Sci USA. 85:(5):1988;1544-1548.
6. Cox G.F., Kunkel L.M. Dystrophies and heart diseases. Curr Opin Cardiol. 12:(3):1997;329-343.
7. Campbell K.P. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell. 80:1995;675-679.
8. Tome F.M., Evangelista T., Leclerc A., et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci Ser III. 317:(4):1994;351-357.
9. Helbling-Leclerc A., Zhang X., Topaloglu H., et al. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet. 11:1995;216-218.
10. Farhadian F., Contard F., Sabri A., Samuel J.L., Rappaport L. Fibronectin and basement membrane in cardiovascular organogenesis and disease pathogenesis. Cardiovasc Res. 32:1996;433-442.
11. Hedin U., Bottger B.A., Forsberg E., Johansson S., Thyberg J. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J Cell Biol. 107:(1):1988;307-319.
12. Lundgren E., Gullberg D., Rubin K., Borg T.K., Terracio M.J., Terracio L. In vitro studies on adult cardiac myocytes. attachment and biosynthesis of collagen type IV and laminin. J Cell Physiol. 136:(1):1988;43-53.
13. Glukhova M., Koteliansky V., Fondacci C., Marotte F., Rappaport L. Laminin variants and integrin laminin receptors in developing and adult human smooth muscle. Dev Biol. 157:(2):1993;437-447.
14. Samuel J.L., Barrieux A., Dufour S., et al. Accumulation of fetal fibronectin mRNAs during the development of rat cardiac hypertrophy induced by pressure overload. J Clin Invest. 88:1991;1737-1746.
15. Farhadian F., Barrieux A., Lortet S., et al. Differential splicing of fibronectin pre-messenger ribonucleic acid during cardiac ontogeny and development of hypertrophy in the rat. Lab Invest. 71:(4):1994;552-559.
16. Chapman D., Weber K.T., Eghbali M. Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium. Circ Res. 67:1990;787-794.
17. Villareal F.J., Dillmann W.H. Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. Am J Physiol. 262:(6Pt2):1992;H1861-1866.
18. Robert V., Van Thiem N., Cheav S.L., Mouas C., Swynghedauw B., Delcayre C. Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension. Hypertension. 24:1994;30-36.
19. Robert V., Silvestre J.S., Charlemagne D., et al. Biological determinants of aldosterone-induced cardiac fibrosis in rats. Hypertension. 26:1995;971-978.
20. Grimm D., Kromer E.P., Bocker W., et al. Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: effects of angiotensin converting enzyme inhibition. J Hypertens. 16:1998;1345-1355.
21. Sainte Beuve C., Allen P.D., Dambrin G., et al. Cardiac calcium release channel (ryanodine receptor) in control and cardiomyopathic human hearts: mRNA and protein contents are differentially regulated. J Mol Cell Cardiol. 29:1997;1237-1246.
22. Contard F., Koteliansky V., Marotte F., Dubus I., Rappaport L., Samuel J.L. Specific alterations in the the distribution of extracellular matrix components within rat myocardium during the development of pressure overload. Lab Invest. 64:1991;65-67.
23. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
24. Schiaffino S., Samuel J.L., Sassoon D., et al. Nonsynchronous accumulation of α-skeletal actin and β-myosin heavy chain mRNAs during early stages of pressure overloaded-induced cardiac hypertrophy demonstrated by in situ hybridization. Circ Res. 64:1989;937-948.
25. Dussault J.H., Labrie F. Development of the hypothalamic-pituitary-thyroid axis in the neonatal rat. Endocrinology. 97:(5):1975;1321-1324.
26. Kim H., Yoon C.S., Kim H., Rah B. Expression of extracellular matrix components fibronectin and laminin in the human fetal heart. Cell Struct Funct. 24:1999;19-26.
27. Anversa P., Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res. 83:1998;1-14.
28. Soonpaa M.H., Field L.J. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res. 83:1998;15-26.
29. Miner J.H., Patton B.L., Lentz S.I., et al. The laminin alpha chains: expression, developmental transitions, and chromosomal locations of alpha1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel alpha3 isoform. J Cell Biol. 137:1997;685-701.
30. Hierck B.P., Poelmann R.E., van Iperen L., Brouwer A., Gittenberger-de-Groot A.C. Differential expression of alpha-6 and other subunits of laminin binding integrins during development of the murine heart. Dev Dyn. 206:1996;100-111.
31. Sunada Y., Bernier S.M., Kozak C.A., Yamada Y., Campbell K.P. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J Biol Chem. 269:(19):1994;13729-13732.
32. Xu H., Christmas P., Wu X.R., Wewer U.M., Engvall E. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc Natl Acad Sci USA. 91:(12):1994;5572-5576.
33. Kuang W., Xu H., Vachon P.H., et al. Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models. J Clin Invest. 102:1998;844-852.
34. Kuang W., Xu H., Vachon P.H., Engvall E. Disruption of the lama2 gene in embryonic stem cells. laminin alpha 2 is necessary for sustenance of mature muscle cells. Exp Cell Res. 25:1998;117-125.
35. Grimm D., Cameron D., Griese D.P., Riegger G.A., Kromer E.P. Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction. Cardiovasc Res. 40:1998;297-306.
36. Farwell A.P., Dubord-Tomasetti S.A. Thyroid hormone regulates the expression of laminin in the developing rat cerebellum. Endocrinology. 140:1999;4221-4227.
37. George E.L., Baldwin H.S., Hynes R.O. Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells. Blood. 90:1997;3073-3081.
38. Crawford D.C., Chobanian A.V., Brecher P. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ Res. 74:1994;727-739.
39. Farhadian F., Contard F., Corbier A., Barrieux A., Rappaport L., Samuel J.L. Fibronectin expression during physiological and pathological cardiac growth. J Mol Cell Cardiol. 27:1995;981-990.
40. Samuel J.L., Farhadian F., Sabri A., et al. Expression of fibronectin during fetal and post natal development: An in situ hybridisation and immunohistochemical study. Cardiovasc Res. 28:1994;1653-1661.
41. Knowlton A.A., Connelly C.M., Romo G.M., Mamuya W., Apstein C.S., Brecher P. Rapid expression of fibronectin in the rabbit heart after myocardial infarction with and without reperfusion. J Clin Invest. 89:1992;1060-1068.
42. Ulrich M.M., Janssen A.M., Daemen M.J., et al. Increased expression of fibronectin isoforms after myocardial infarction in rats. J Mol Cell Cardiol. 29:1997;2533-2543.
43. Grimm D., Elsner D., Schunkert H., et al. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc Res. 37:1998;91-100.
44. Iwami K., Ashizawa N., Do Y.S., Graf K., Hsueh W.A. Comparison of ANG II with other growth factors on Egr-1 and matrix gene expression in cardiac fibroblasts. Am J Physiol. 270:1996;H2100-H2107.
45. Schaper J., Hein S. The structural correlate of reduced cardiac function in human dilated cardiomyopathy. Heart Failure. 1:1993;95-111.
46. Vilquin J.T., Kinoshita I., Roy B., et al. Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation. J Cell Biol. 133:1996;185-197.